Day One to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Day One Biopharmaceuticals (Nasdaq: DAWN), a company focused on developing targeted therapies for life-threatening diseases, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. Dr. Jeremy Bender, the company's CEO, will deliver a presentation on Monday, January 13 at 3:45 p.m. Pacific Time / 6:45 p.m. Eastern Time.
Interested parties can access a live audio webcast of the presentation through the Events & Presentations section on Day One's website. The webcast recording will remain available for replay for 30 days after the live presentation.
Day One Biopharmaceuticals (Nasdaq: DAWN), un'azienda specializzata nello sviluppo di terapie mirate per malattie potenzialmente letali, ha annunciato la sua partecipazione al 43° Annual J.P. Morgan Healthcare Conference. Il Dr. Jeremy Bender, CEO dell'azienda, presenterà il suo intervento lunedì 13 gennaio alle 15:45 ora del Pacifico / 18:45 ora dell'Est.
Le parti interessate possono accedere a una diretta audio del webinar tramite la sezione Eventi e Presentazioni sul sito web di Day One. La registrazione del webinar rimarrà disponibile per la visione per 30 giorni dopo la presentazione dal vivo.
Day One Biopharmaceuticals (Nasdaq: DAWN), una empresa enfocada en desarrollar terapias dirigidas para enfermedades amenazantes para la vida, ha anunciado su participación en la 43ª Conferencia Anual de J.P. Morgan Healthcare. El Dr. Jeremy Bender, CEO de la empresa, realizará una presentación el lunes 13 de enero a las 3:45 p.m. hora del Pacífico / 6:45 p.m. hora del Este.
Las partes interesadas pueden acceder a una transmisión en vivo del audio de la presentación a través de la sección de Eventos y Presentaciones en el sitio web de Day One. La grabación de la transmisión estará disponible para su reproducción durante 30 días después de la presentación en vivo.
데이 원 바이오제약 (Nasdaq: DAWN)은 생명을 위협하는 질병을 위한 표적 치료제를 개발하는 데 중점을 둔 회사로, 제43회 연례 J.P. 모건 헬스케어 컨퍼런스에 참가한다고 발표했습니다. 제레미 벤더 박사가 회사의 CEO로서 1월 13일 월요일 오후 3시 45분 태평양 표준시 / 오후 6시 45분 동부 표준시에 발표를 진행할 예정입니다.
관심 있는 분들은 데이 원 웹사이트의 이벤트 및 발표 섹션을 통해 발표의 라이브 오디오 웹캐스트를 들을 수 있습니다. 웹캐스트 녹화는 생방송 발표 후 30일 동안 다시 볼 수 있습니다.
Day One Biopharmaceuticals (Nasdaq: DAWN), une entreprise axée sur le développement de thérapies ciblées pour des maladies menaçantes pour la vie, a annoncé sa participation à la 43e Conférence Annuelle J.P. Morgan Healthcare. Le Dr Jeremy Bender, PDG de l'entreprise, présentera le lundi 13 janvier à 15h45 heure du Pacifique / 18h45 heure de l'Est.
Les parties intéressées peuvent accéder à un webinaire audio en direct de la présentation via la section Événements & Présentations sur le site de Day One. L'enregistrement du webinaire restera disponible à la rediffusion pendant 30 jours après la présentation en direct.
Day One Biopharmaceuticals (Nasdaq: DAWN), ein Unternehmen, das sich auf die Entwicklung zielgerichteter Therapien für lebensbedrohliche Krankheiten konzentriert, hat seine Teilnahme an der 43. jährlichen J.P. Morgan Healthcare Conference angekündigt. Dr. Jeremy Bender, der CEO des Unternehmens, wird am Montag, den 13. Januar um 15:45 Uhr Pazifischer Zeit / 18:45 Uhr Östlicher Zeit eine Präsentation halten.
Interessierte können über den Bereich Veranstaltungen & Präsentationen auf der Website von Day One auf einen Live-Audio-Webcast der Präsentation zugreifen. Die Aufnahme des Webcasts bleibt 30 Tage nach der Live-Präsentation für eine Wiederholung verfügbar.
- None.
- None.
BRISBANE, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced that Dr. Jeremy Bender, chief executive officer, will present during the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13 at 3:45 p.m. Pacific Time / 6:45 p.m. Eastern Time.
A live audio webcast of the presentation will be available by visiting the Events & Presentations section of the Company’s website at www.dayonebio.com. An archived replay of the webcast will be available for 30 days following the live presentation.
About Day One Biopharmaceuticals
Day One Biopharmaceuticals believes when it comes to pediatric cancer, we can do better. The Company was founded to address a critical unmet need: the dire lack of therapeutic development in pediatric cancer. Inspired by “The Day One Talk” that physicians have with patients and their families about an initial cancer diagnosis and treatment plan, Day One aims to re-envision cancer drug development and redefine what’s possible for all people living with cancer—regardless of age—starting from Day One.
Day One partners with leading clinical oncologists, families, and scientists to identify, acquire, and develop important targeted cancer treatments. The Company’s pipeline includes tovorafenib (OJEMDA™), DAY301 and a VRK1 inhibitor program.
Day One is based in Brisbane, California. For more information, please visit www.dayonebio.com or find the Company on LinkedIn or X.
Day One uses its Investor Relations website (ir.dayonebio.com), its X handle (x.com/DayOneBio), and LinkedIn Home Page (linkedin.com/company/dayonebio) as a means of disseminating or providing notification of, among other things, news or announcements regarding its business or financial performance, investor events, press releases, and earnings releases, and as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD.
DAY ONE MEDIA
Laura Cooper, Head of Communications
media@dayonebio.com
DAY ONE INVESTORS
LifeSci Advisors, PJ Kelleher
pkelleher@lifesciadvisors.com
FAQ
When is Day One Biopharmaceuticals (DAWN) presenting at the J.P. Morgan Healthcare Conference?
How can investors watch Day One's (DAWN) J.P. Morgan Healthcare Conference presentation?
How long will Day One's (DAWN) J.P. Morgan presentation replay be available?
Who is presenting for Day One Biopharmaceuticals (DAWN) at the J.P. Morgan Healthcare Conference?
Which annual J.P. Morgan Healthcare Conference is Day One (DAWN) presenting at?
